Status dystonicus resembling the intrathecal baclofen withdrawal syndrome: a case report and review of the literature.
BACKGROUND
Status dystonicus is a rare but life-threatening disorder characterized by increasingly frequent and severe episodes of generalized dystonia that may occur in patients with primary or secondary dystonia. Painful and repetitive spasms interfere with respiration and may cause metabolic disturbances such as hyperpyrexia, dehydration, respiratory insufficiency, and acute renal failure secondary to rhabdomyolysis. Intrathecally administered baclofen, delivered by an implantable pump system, is widely used for the treatment of refractory spasticity. Abrupt cessation of intrathecal baclofen infusion has been associated with a severe withdrawal syndrome comprised of dystonia, autonomic dysfunction, hyperthermia, end-organ failure and sometimes death. The aetiology of this syndrome is not well understood. Status dystonicus describes the episodes of acute and life-threatening generalized dystonia, which occasionally manifest themselves in patients with dystonic syndromes.


METHODS
We present the case of a nine-year-old Caucasian boy who experienced a severe episode of status dystonicus with no known cause and clinical features resembling those described in intrathecal baclofen withdrawal. Our patient subsequently underwent the placement of an intrathecal baclofen pump without incident.


CONCLUSIONS
The similarity between the clinical features of the case we present and those reported in connection to abrupt withdrawal of intrathecal baclofen is emphasized. Several drugs, although not intrathecal baclofen withdrawal, have previously been associated with status dystonicus. The similarity between the life-threatening dystonic episode experienced by our patient, and those reported in intrathecal baclofen withdrawal, highlights the possibility that, rather than representing a true physiological withdrawal syndrome, abrupt withdrawal of intrathecal baclofen may simply precipitate an episode of status dystonicus in susceptible individuals. The clinical similarities between the intrathecal baclofen withdrawal syndrome and status dystonicus have not previously been highlighted.
Muirhead
William
W
School of Medicine, University of Nottingham, Queens Medical Centre, Derby Road, Nottingham, NG7 2UH, UK. mzyawm@nottingham.ac.uk.
Jalloh
Ibrahim
I
Vloeberghs
Michael
M
Brain. 1998 Feb;121 ( Pt 2):243-52
9549503
Am J Phys Med Rehabil. 2007 Dec;86(12):994-7
18090440
Pediatr Emerg Care. 2008 Oct;24(10):691-3
19240673
Anaesth Intensive Care. 2005 Aug;33(4):534-7
16119501
Pediatr Neurosurg. 2003 Jul;39(1):1-6
12784068
Arch Phys Med Rehabil. 2002 Jun;83(6):735-41
12048649
Am J Phys Med Rehabil. 2003 Jun;82(6):489-92
12820794
Neurology. 1982 Oct;32(10):1195-7
6889706
Dev Med Child Neurol. 2000 Aug;42(8):561-5
10981935
Arch Phys Med Rehabil. 2003 May;84(5):638-42
12736874
Pediatr Emerg Care. 2004 Nov;20(11):759-64
15502658
Childs Nerv Syst. 2002 Oct;18(9-10):522-5
12382179
J Emerg Med. 2003 May;24(4):423-7
12745045
Arch Phys Med Rehabil. 2007 Nov;88(11):1468-71
17964889
Mov Disord. 2007 May 15;22(7):963-8
17427939